FORWARD PHARMA A/S — Credit Rating and Financial Key Figures
CVR number: 28865880
Strandvejen 125, 2900 Hellerup
investors@forward-pharma.com
www.forward-pharma.com
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Other operating income | 3 959.10 | 5 732.63 | 6 082.52 | 1 689.03 | 1 046.91 |
| External services | -11 722.82 | -16 545.56 | -17 714.31 | -7 819.63 | -10 504.82 |
| Gross profit | -7 763.73 | -10 812.93 | -11 631.79 | -6 130.61 | -9 457.91 |
| Employee benefit expenses | -5 054.59 | -2 876.58 | -3 074.48 | -1 827.02 | -1 838.13 |
| Total depreciation | -11 502.47 | -11 189.75 | |||
| EBIT | -24 320.79 | -24 879.26 | -14 706.28 | -7 957.63 | -11 296.04 |
| Other financial income | 693.61 | 13 734.50 | 13 519.30 | 16 166.55 | 73 681.32 |
| Other financial expenses | -18 575.53 | -1 126.38 | -1 112.39 | -9 888.75 | -4 068.60 |
| Net income from associates (fin.) | -29 183.47 | -2 152.69 | -68 248.25 | ||
| Pre-tax profit | -42 202.71 | -12 271.14 | -31 482.85 | -3 832.52 | -9 931.57 |
| Income taxes | 1.02 | 85 859.22 | |||
| Net earnings | -42 201.69 | -12 271.14 | -31 482.85 | -3 832.52 | 75 927.65 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 314 835.68 | 305 177.53 | 278 702.10 | 278 412.20 | 280 041.15 |
| Investments total | 314 835.68 | 305 177.53 | 278 702.10 | 278 412.20 | 280 041.15 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 451.80 | 1 114.55 | 5 040.81 | ||
| Prepayments and accrued income | 2 020.03 | 3 195.25 | 3 005.22 | 5 041.46 | |
| Current other receivables | 170.70 | 142.28 | 4.77 | 2 145.83 | 50 139.53 |
| Current deferred tax assets | 1 189.11 | 344.85 | 86 188.55 | ||
| Short term receivables total | 3 831.63 | 4 452.09 | 8 050.80 | 7 532.13 | 136 328.08 |
| Other current investments | 376 186.33 | 342 439.66 | |||
| Cash and bank deposits | 256 198.49 | 251 430.66 | 243 125.59 | 42 553.93 | 76 543.59 |
| Cash and cash equivalents | 256 198.49 | 251 430.66 | 243 125.59 | 418 740.26 | 418 983.25 |
| Balance sheet total (assets) | 574 865.81 | 561 060.28 | 529 878.49 | 704 684.59 | 835 352.48 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 964.88 | 982.64 | 998.77 | 1 014.74 | 1 014.74 |
| Other reserves | 44 169.04 | 44 179.10 | 44 179.18 | ||
| Retained earnings | 471 174.46 | 428 972.77 | 416 701.63 | 429 263.56 | 411 387.85 |
| Profit of the financial year | -42 201.69 | -12 271.14 | -31 482.85 | -3 832.52 | 75 927.65 |
| Shareholders equity total | 474 106.68 | 461 863.38 | 430 396.73 | 426 445.78 | 488 330.23 |
| Non-current liabilities total | |||||
| Current trade creditors | 2 732.80 | 342.01 | 1 950.62 | 627.10 | 589.32 |
| Current owed to group member | 95 334.02 | 96 284.83 | 97 245.19 | 277 565.44 | 344 381.32 |
| Other non-interest bearing current liabilities | 290.56 | 47.63 | 285.95 | 46.28 | 2 051.60 |
| Accruals and deferred income | 2 401.75 | 2 522.42 | |||
| Current liabilities total | 100 759.13 | 99 196.90 | 99 481.76 | 278 238.82 | 347 022.24 |
| Balance sheet total (liabilities) | 574 865.81 | 561 060.28 | 529 878.49 | 704 684.59 | 835 352.48 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.